Biosensors Market by Application (POC, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food & Beverages Industry), Technology, Product (Wearable and Non-Wearable), and Geography - Global Forecast to 2022

 Published On: Apr, 2017 |    No of Pages: 184 |  Published By: MarketsandMarkets | Format: PDF
Download Free Sample
Increasing requirement for glucose monitoring for diabetic individuals worldwide is fueling the growth of the biosensors market

The biosensors market is expected to grow at a CAGR of 8.84% between 2017 and 2022 to reach USD 27.06 billion by 2022 from USD 15.96 billion in 2016. Glucose monitoring devices are gaining traction due to increasing incidences and prevalence of lifestyle diseases, such as diabetes, that require regular monitoring. Moreover, the proven efficacy of such testing kits has resulted in their growing adoption by doctors. According to International Diabetes Federation, the number of people suffering from diabetes is expected to grow from 415 million in 2015 to almost 642 million by 2040 worldwide.

Increasing demand for point-of-care applications is driving the growth of the biosensors market

The increasing demand for biosensors is attributed to the availability of point-of-care testing methods. As most POC tests are in the vicinity of patient care sites, the requirement for complex infrastructure and training is low. The growth in the POC market is attributed to the advancements in biosensors technology and increasing demand for quick test results. Also, growing prevalence of infectious and lifestyle diseases, such as cardiac complications and diabetes, is increasing the demand for POC diagnostics. Awareness among people for easy and convenient ways to get faster test results is also contributing to the growing demand. Also, physicians prefer POC for quick decision-making to prescribe disease-specific drugs. On the contrary, doctors previously had to wait before starting with symptomatic treatment, as test procedures used to take a considerably longer amount of time to yield results.

North America is the major market for biosensors

North America is likely to hold the largest share of the overall biosensors market in 2017. POC diagnostics is the fastest-growing applications for biosensors in North America. The main reason behind the growth of the POC segment is the increase in addressable patient population base. According to the American Medical Association and American Medical Group Association, more than 50% Americans were living with one or more chronic disease(s) till 2012. The number of Americans suffering from chronic diseases was around 125 billion in 2000, which is expected to reach around 157 billion by 2022. The baby boomer population is witnessing a growth in incidences of chronic and infectious diseases, According to the US Census Bureau, the number of individuals over the age of 65 was 39.6 billion in 2009, which is expected to increase to 72.1 billion by 2030.

The biosensors market APAC is expected grow at a high rate between 2017 and 2022. The other major factors contributing to the growth of the biosensors market in APAC include the development of healthcare systems and increasing number of lifestyle diseases in the region. APAC is the amalgamation of some of the leading markets such as China, Japan, and India. The growth of the biosensors market in APAC for POC applications can be attributed to the huge population base, increasing investments in the healthcare sector, growing focus of key industry players on technological advancements, and significant R&D pertaining to biosensors. In September 2017, PatientSafe Solutions (US) garnered strategic investments of around USD 27 billion from EDBI. This fund was used to augment the expansion of PatientSafe’s PatientTouch System, a POC mobile solution, in APAC.

In the process of determining and verifying the market size for several segments and subsegments gathered through secondary research, extensive primary interviews have been conducted with key officials in the biosensors industry.

The break-up of the primary participants has been shown below.

• By Company Type: Tier 1 = 35 %, Tier 2 = 45%, and Tier 3 = 20%
• By Designation: C-Level Executives = 35%, Directors = 25%, and Others = 40%
• By Region: North America = 45%, Europe = 20%, APAC = 30%, and RoW = 5%

The report also profiles the key players in the biosensors market and analyzes their market ranking. The prominent players profiled in this report are Abbott Point of Care Inc. (US), Medtronic, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), Siemens AG (Germany), LifeScan, Inc. (US), LifeSensors Inc. (US), Nova Biomedical Corp. (US), Acon Laboratories Inc. (US), Universal Biosensors (Australia), Pharmaco-Kinesis Corporation (PKC) (US), Bayer Healthcare AG (Germany), Biacore (UK), Bio-Rad Laboratories Inc. (US), Biosensors International Ltd.(Singapore), Ercon, Inc. (US), DuPont (US), and Sysmex Corporation (Japan).

Research Coverage:

This research report categorizes the biosensors market on the basis of application, technology, product, and geography. The report also provides the Porter’s five forces analysis, along with a description of each of its forces and their respective impact on the biosensors market; description of major drivers, restraints, challenges, and opportunities pertaining to the market; value chain analysis; and market ranking analysis.

Reasons to Buy the Report

The report will help leaders/new entrants in this market in the following ways:
1. This report segments the biosensors market comprehensively and provides the closest market size estimation for all subsegments across different regions.
2. The report will help stakeholders understand the pulse of the market and provide them with the information on key drivers, restraints, challenges, and opportunities for the biosensors market.
3. This report will help stakeholders understand their competitors better and gain more insights to improve their position in the business. The competitive landscape section describes competitor ecosystem and various strategies implemented by the companies such as new product developments, partnerships, and mergers and acquisitions.
TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 STUDY SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THIS STUDY 18
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 22
2.1.1.1 List of major secondary sources 22
2.1.1.2 Key data from secondary sources 22
2.1.2 PRIMARY DATA 23
2.1.2.1 Primary interviews with experts 23
2.1.2.2 Breakdown of primaries 23
2.1.2.3 Key data from primary sources 24
2.1.2.4 Key industry insights 25
2.2 MARKET SIZE ESTIMATION 26
2.2.1 BOTTOM-UP APPROACH 26
2.2.2 TOP-DOWN APPROACH 27
2.2.2.1 Estimating value and volume from secondary treasures 27
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.4 ASSUMPTIONS 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 34
4.1 ATTRACTIVE GROWTH OPPORTUNITIES IN THE BIOSENSORS MARKET 34
4.2 BIOSENSORS MARKET, BY APPLICATION 34
4.3 BIOSENSORS MARKET, BY TECHNOLOGY AND REGION 35
4.4 BIOSENSORS MARKET, BY PRODUCT 35
4.5 BIOSENSORS MARKET, BY COUNTRY 36

5 MARKET OVERVIEW 37
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 39
5.2.1.1 Emergence of nanotechnology-based biosensors 39
5.2.1.1 Significant technological advancements in the past few years 39
5.2.1.2 Increasing use of biosensors to monitor glucose levels in individuals with diabetes 40
5.2.1.3 Increased demand for home-based POC devices 41
5.2.2 RESTRAINTS 41
5.2.2.1 Slow rate of commercialization 41
5.2.2.2 High costs involved in research and development 42
5.2.2.3 Reluctance toward the adoption of new treatment practices 42
5.2.3 OPPORTUNITIES 42
5.2.3.1 Emerging market in developing countries 42
5.2.3.2 High-growth opportunities in environmental monitoring, biodefense, and the food industry 43
5.2.4 CHALLENGES 44
5.2.4.1 Government regulations – long certification and approval cycles 44
5.2.4.2 Pricing pressure in the POC market 44

6 INDUSTRY TRENDS 45
6.1 INTRODUCTION 45
6.2 VALUE CHAIN ANALYSIS 45
6.3 INDUSTRY TRENDS 47
6.4 PORTER’S FIVE FORCES ANALYSIS 48
6.4.1 THREAT OF NEW ENTRANTS 48
6.4.2 THREATS OF SUBSTITUTES 49
6.4.3 BARGAINING POWER OF SUPPLIERS 49
6.4.4 BARGAINING POWER OF BUYERS 50
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 50
6.5 STARTUP SCENARIO 51
6.5.1 START-UP COMPANIES 51

7 MARKET, BY TECHNOLOGY 53
7.1 INTRODUCTION 54
7.2 ELECTROCHEMICAL BIOSENSORS 56
7.2.1 AMPEROMETRIC SENSORS 57
7.2.1.1 Blood glucose sensors 57
7.2.2 POTENTIOMETRIC SENSORS 58
7.2.2.1 Immunosensors 58
7.2.3 CONDUCTOMETRIC SENSORS 58
7.3 OPTICAL BIOSENSORS 59
7.3.1 SURFACE PLASMON RESONANCE (SPR) 60
7.3.2 CALORIMETRIC BIOSENSORS 60
7.3.3 FLUORESCENCE BIOSENSORS 60
7.4 PIEZOELECTRIC BIOSENSORS 61
7.4.1 ACOUSTIC BIOSENSORS 62
7.4.2 MICROCANTILEVER BIOSENSORS 62
7.5 THERMAL BIOSENSORS 63
7.6 NANOMECHANICAL BIOSENSORS 63
7.7 OTHERS 63

8 BIOSENSORS MARKET, BY PRODUCT 64
8.1 INTRODUCTION 65
8.2 WEARABLE BIOSENSORS 65
8.2.1 WRISTWEAR 66
8.2.2 EYEWEAR 67
8.2.3 FOOTWEAR 68
8.2.4 NECKWEAR 69
8.2.5 BODYWEAR 69
8.2.6 OTHERS 70
8.3 NON-WEARABLE BIOSENSORS 70

9 BIOSENSORS MARKET, BY APPLICATION 72
9.1 INTRODUCTION 73
9.2 POINT OF CARE (POC) 74
9.2.1 BIOSENSORS MARKET FOR POC APPLICATIONS, BY GEOGRAPHY 75
9.2.2 GLUCOSE MONITORING 78
9.2.3 CARDIAC MARKERS 79
9.2.4 INFECTIOUS DISEASES 80
9.2.5 COAGULATION MONITORING 81
9.2.6 PREGNANCY & FERTILITY TESTING 82
9.2.7 BLOOD GAS & ELECTROLYTES 82
9.2.8 TUMOR OR CANCER MARKERS 83
9.2.9 URINALYSIS TESTING 84
9.2.10 CHOLESTEROL TESTS 85
9.2.11 OTHERS 86
9.3 HOME DIAGNOSTICS 86
9.4 RESEARCH LABS 90
9.4.1 DRUG DEVELOPMENT 90
9.5 BIODEFENCE 94
9.5.1 CRIME DETECTION 94
9.6 ENVIRONMENTAL MONITORING 98
9.6.1 WASTEWATER TREATMENT 98
9.7 FOOD & BEVERAGES INDUSTRY 102

10 BIOSENSORS MARKET, BY GEOGRAPHY 105
10.1 INTRODUCTION 106
10.2 NORTH AMERICA 107
10.3 EUROPE 110
10.4 ASIA PACIFIC (APAC) 113
10.5 REST OF THE WORLD (ROW) 116

11 COMPETITIVE LANDSCAPE 117
11.1 OVERVIEW 117
11.2 KEY PLAYERS IN BIOSENSORS MARKET 117
11.3 DIVE CHART ANALYSIS 120
11.3.1 VANGUARDS 120
11.3.2 DYNAMIC 120
11.3.3 INNOVATOR 120
11.3.4 EMERGING 120
11.4 COMPETITIVE BENCHMARKING 122
11.4.1 PRODUCT OFFERINGS 122
11.4.2 BUSINESS STRATEGY 123
*Top 25 companies analyzed for this study are - F. Hoffman-La Roche Ltd. (Switzerland), Abbott Point of Care Inc. (US), Medtronic, Inc. (US), LifeScan Inc. (US), Universal Biosensors Inc. (Australia), DuPont (US), Sysmex Corporation (Japan), Bio-Rad laboratories Inc. (US), Pharmaco-Kinesis Corporation (PKC) (US), Nova Biomedical Corp. (US), ACON Laboratories, Inc. (US), LifeSensors Inc. (US), Biacore (Sweden), Biosensors International Pte. Ltd. (US), Innovative Biosensors, Inc. (US), Xsensio (Switzerland), Theron, Inc. (US), Cranfield Biotechnology Centre (UK), Ercon, Inc. (US), Bio-Rad Laboratories Inc. (US), Draeger Safety (US), Molecular Devices Corp. (US), M-Biotech, NeuroSky, Inc. (US), and QTL Biosystems, LLC (US)
11.5 COMPETITIVE SITUATIONS AND TRENDS 124
11.5.1 NEW PRODUCT LAUNCHES AND DEVELOPMENTS 125
11.5.2 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS 126
11.5.3 MERGERS AND ACQUISITIONS 127
11.5.4 EXPANSIONS 127

12 COMPANY PROFILES 128
12.1 INTRODUCTION 128 (Business Overview, Products offered & Services strategies, Key Insights, Recent Developments, MnM View)*
12.2 ABBOTT POINT OF CARE, INC. 129
12.3 F. HOFFMAN-LA ROCHE LTD. 132
12.4 MEDTRONIC INC. 135
12.5 UNIVERSAL BIOSENSORS, INC. 139
12.6 SIEMENS AG 143
12.7 LIFESCAN, INC. 146
12.8 LIFESENSORS, INC. 148
12.9 NOVA BIOMEDICAL 150
12.10 ACON LABORATORIES, INC. 152
12.11 PHARMACO-KINESIS CORPORATION 154
12.12 BAYER HEALTHCARE AG 156
12.13 BIO-RAD LABORATORIES, INC. 159
12.14 BIACORE 162
12.15 BIOSENSORS INTERNATIONAL PTE. LTD. 163
12.16 ERCON, INC. 164
12.17 DUPONT 165
12.18 SYSMEX CORPORATION 168
12.19 KEY INNOVATORS 172
12.19.1 NEUROSKY, INC. 172
12.19.2 GRAPHENE FRONTIERS 172
12.19.3 HMICRO INC. 173

*Details on Business Overview, Products offered & Services strategies, Key Insights, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX 174
13.1 INSIGHTS OF INDUSTRY EXPERTS 174
13.2 DISCUSSION GUIDE 175
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 178
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 180
13.5 AVAILABLE CUSTOMIZATIONS 181
13.6 RELATED REPORTS 181
13.7 AUTHOR DETAILS 182

LIST OF TABLES

TABLE 1 BIOSENSORS MARKET, BY TECHNOLOGY, 2015–2022 (USD BILLION) 54
TABLE 2 DIFFERENCES BETWEEN VARIOUS ELECTROCHEMICAL BIOSENSORS 56
TABLE 3 GLUCOSE SENSORS AND DEVICES APPROVED BY FOOD AND DRUG ADMINISTRATION (FDA) 57
TABLE 4 MARKET FOR ELECTROCHEMICAL BIOSENSORS, BY TECHNOLOGY, 2015–2022 (USD BILLION) 59
TABLE 5 MARKET FOR OPTICAL BIOSENSORS, BY TECHNOLOGY, 2015–2022 (USD BILLION) 61
TABLE 6 BIOSENSORS MARKET, BY PRODUCT, 2015–2022 (USD BILLION) 65
TABLE 7 MARKET FOR WEARABLE BIOSENSORS, BY APPLICATION, 2015–2022 (USD MILLION) 66
TABLE 8 MARKET FOR WRISTWEAR BIOSENSORS, BY APPLICATION, 2015–2022 (USD MILLION) 67
TABLE 9 MARKET FOR EYEWEAR HEADWEAR BIOSENSORS, BY APPLICATION, 2015–2022 (USD MILLION) 68
TABLE 10 MARKET FOR FOOTWEAR BIOSENSORS, BY APPLICATION, 2015–2022 (USD MILLION) 68
TABLE 11 MARKET FOR NECKWEAR BIOSENSORS, BY APPLICATION, 2015–2022 (USD MILLION) 69
TABLE 12 MARKET FOR BODYWEAR BIOSENSORS, BY APPLICATION, 2015–2022 (USD MILLION) 69
TABLE 13 MARKET FOR OTHER WEARABLE BIOSENSORS, BY APPLICATION, 2015–2022 (USD MILLION) 70
TABLE 14 MARKET FOR NON-WEARABLE BIOSENSORS, BY APPLICATION, 2015–2022 (USD BILLION) 70
TABLE 15 BIOSENSORS MARKET, BY APPLICATION, 2015–2022 (USD BILLION) 73
TABLE 16 BIOSENSORS MARKET FOR POC APPLICATIONS, BY TYPE, 2015–2022 (USD BILLION) 74
TABLE 17 BIOSENSORS MARKET FOR POC APPLICATIONS, BY REGION, 2015–2022 (USD BILLION) 75
TABLE 18 BIOSENSORS MARKET FOR POC APPLICATIONS IN NORTH AMERICA, BY COUNTRY, 2015–2022 (USD BILLION) 76
TABLE 19 BIOSENSORS MARKET FOR POC APPLICATIONS IN EUROPE, BY COUNTRY/REGION, 2015–2022 (USD BILLION) 76
TABLE 20 BIOSENSORS MARKET FOR POC APPLICATIONS IN APAC, BY COUNTRY/REGION, 2015–2022 (USD BILLION) 77
TABLE 21 BIOSENSORS MARKET FOR POC APPLICATIONS, BY PRODUCT, 2015–2022 (USD BILLION) 77
TABLE 22 MARKET FOR WEARABLE BIOSENSORS FOR POC APPLICATIONS, BY TYPE, 2015–2022 (USD BILLION) 78
TABLE 23 BIOSENSORS MARKET FOR GLUCOSE MONITORING, BY REGION, 2015–2022 (USD BILLION) 79
TABLE 24 BIOSENSORS MARKET FOR CARDIAC MARKERS, BY REGION, 2015–2022 (USD MILLION) 80
TABLE 25 BIOSENSORS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2015–2022 (USD MILLION) 80
TABLE 26 BIOSENSORS MARKET FOR COAGULATION MONITORING, BY REGION, 2015–2022 (USD MILLION) 81
TABLE 27 BIOSENSORS MARKET FOR PREGNANCY & FERTILITY TESTING, BY REGION, 2015–2022 (USD MILLION) 82
TABLE 28 BIOSENSORS MARKET FOR BLOOD GAS & ELECTROLYTES, BY REGION, 2015–2022 (USD MILLION) 82
TABLE 29 BIOSENSORS MARKET FOR TUMOR OR CANCER MARKERS, BY REGION, 2015–2022 (USD MILLION) 84
TABLE 30 BIOSENSORS MARKET FOR URINALYSIS TESTING, BY REGION, 2015–2022 (USD MILLION) 84
TABLE 31 BIOSENSORS MARKET FOR CHOLESTEROL TESTS, BY REGION, 2015–2022 (USD MILLION) 85
TABLE 32 BIOSENSORS MARKET FOR OTHER POC APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 86
TABLE 33 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY REGION, 2015–2022 (USD BILLION) 87
TABLE 34 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS IN NORTH AMERICA, BY COUNTRY, 2015–2022 (USD MILLION) 88
TABLE 35 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS IN EUROPE, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 88
TABLE 36 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS IN APAC, BY COUNTRY/REGION, 2015–2022 (USD BILLION) 89
TABLE 37 BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS, BY PRODUCT, 2015–2022 (USD BILLION) 89
TABLE 38 MARKET FOR WEARABLE BIOSENSORS FOR HOME DIAGNOSTICS APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 90
TABLE 39 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY REGION, 2015–2022 (USD BILLION) 91
TABLE 40 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS IN NORTH AMERICA, BY COUNTRY, 2015–2022 (USD MILLION) 91
TABLE 41 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS IN EUROPE, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 92
TABLE 42 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS IN APAC, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 92
TABLE 43 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS, BY PRODUCT, 2015–2022 (USD BILLION) 93
TABLE 44 MARKET FOR WEARABLE BIOSENSORS FOR RESEARCH LAB APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 93
TABLE 45 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 95
TABLE 46 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS IN NORTH AMERICA, BY COUNTRY, 2015–2022 (USD MILLION) 95
TABLE 47 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS IN EUROPE, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 96
TABLE 48 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS IN APAC, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 96
TABLE 49 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS, BY PRODUCT, 2015–2022 (USD MILLION) 97
TABLE 50 MARKET FOR WEARABLE BIOSENSORS FOR BIODEFENSE APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 97
TABLE 51 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY REGION, 2015–2022 (USD BILLION) 99
TABLE 52 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS IN NORTH AMERICA, BY COUNTRY, 2015–2022 (USD MILLION) 99
TABLE 53 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS IN EUROPE, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 100
TABLE 54 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS IN APAC, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 100
TABLE 55 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY PRODUCT, 2015–2022 (USD BILLION) 101
TABLE 56 MARKET FOR WEARABLE BIOSENSORS FOR ENVIRONMENTAL MONITORING APPLICATIONS, BY TYPE, 2015–2022 (USD BILLION) 101
TABLE 57 ENZYME BIOSENSOR FOR DETECTING FOOD COMPONENTS 102
TABLE 58 BIOSENSORS MARKET FOR FOOD & BEVERAGES INDUSTRY, BY REGION, 2015–2022 (USD MILLION) 102
TABLE 59 BIOSENSORS MARKET FOR THE FOOD & BEVERAGES INDUSTRY IN NORTH AMERICA, BY COUNTRY, 2015–2022 (USD MILLION) 103
TABLE 60 BIOSENSORS MARKET FOR THE FOOD & BEVERAGES INDUSTRY IN EUROPE, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 103
TABLE 61 BIOSENSORS MARKET FOR THE FOOD & BEVERAGES INDUSTRY IN APAC, BY COUNTRY/REGION, 2015–2022 (USD BILLION) 104
TABLE 62 BIOSENSORS MARKET, BY REGION, 2015–2022 (USD BILLION) 107
TABLE 63 BIOSENSORS MARKET IN NORTH AMERICA, BY COUNTRY, 2015–2022 (USD BILLION) 109
TABLE 64 BIOSENSORS MARKET IN NORTH AMERICA, BY APPLICATION, 2015–2022 (USD BILLION) 109
TABLE 65 BIOSENSORS MARKET IN EUROPE, BY COUNTRY/REGION, 2015–2022 (USD BILLION) 112
TABLE 66 BIOSENSORS MARKET IN EUROPE, BY APPLICATION, 2015–2022 (USD BILLION) 112
TABLE 67 BIOSENSORS MARKET IN APAC, BY COUNTRY/REGION, 2015–2022 (USD BILLION) 115
TABLE 68 BIOSENSORS MARKET IN APAC, BY APPLICATION, 2015–2022 (USD BILLION) 115
TABLE 69 BIOSENSORS MARKET IN ROW, BY APPLICATION, 2015–2022 (USD MILLION) 116
TABLE 70 NEW PRODUCT LAUNCHES AND DEVELOPMENTS (2014–2017) 125
TABLE 71 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS (2016—2017) 126
TABLE 72 MERGERS AND ACQUISITIONS (2015–2017) 127
TABLE 73 EXPANSIONS (2016 & 2017) 127

LIST OF FIGURES

FIGURE 1 BIOSENSOR MARKET: PROCESS FLOW OF MARKET SIZE ESTIMATION 20
FIGURE 2 BIOSENSORS MARKET: RESEARCH DESIGN 21
FIGURE 3 BIOSENSORS MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 26
FIGURE 4 BIOSENSORS MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 27
FIGURE 5 DATA TRIANGULATION 28
FIGURE 6 POINT OF CARE APPLICATIONS TO HOLD THE LARGEST SIZE OF THE BIOSENSORS MARKET BY 2022 31
FIGURE 7 NON-WEARABLE TO DOMINATE THE BIOSENSORS MARKET DURING FORECAST PERIOD 31
FIGURE 8 MARKET FOR OPTICAL BIOSENSORS TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 32
FIGURE 9 NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE BIOSENSORS MARKET IN 2017 33
FIGURE 10 BIOSENSORS MARKET IN APAC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 34
FIGURE 11 POINT OF CARE TO HOLD THE LARGEST SIZE OF THE BIOSENSORS MARKET BY 2022 34
FIGURE 12 ELECTROCHEMICAL BIOSENSORS TO HOLD THE LARGEST SHARE OF THE BIOSENSORS MARKET IN 2017 35
FIGURE 13 NON-WEARABLE BIOSENSORS TO HOLD A LARGER SHARE OF THE BIOSENSORS MARKET BY 2022 35
FIGURE 14 US TO HOLD THE LARGEST SHARE OF THE BIOSENSORS MARKET IN 2017 36
FIGURE 15 INCREASED MONITORING OF DIABETIC INDIVIDUALS AND DEMAND FOR HOME-BASED PC DEVICES TO FUEL THE GROWTH OF THE BIOSENSORS MARKET 38
FIGURE 17 MINIATURIZATION – A LEADING TREND IN THE CURRENT BIOSENSORS MARKET 47
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS 48
FIGURE 19 LOW IMPACT OF THE THREAT OF NEW ENTRANTS ON THE BIOSENSORS MARKET 48
FIGURE 20 MEDIUM IMPACT OF THE THREAT OF SUBSTITUTE ON THE BIOSENSORS MARKET 49
FIGURE 21 MEDIUM IMPACT OF THE BARGAINING POWER OF SUPPLIER ON THE BIOSENSORS MARKET 49
FIGURE 22 HIGH IMPACT OF THE BARGAINING POWER OF BUYERS ON THE BIOSENSORS MARKET 50
FIGURE 23 MEDIUM IMPACT OF THE INTENSITY OF COMPETITIVE RIVALRY ON THE BIOSENSORS MARKET 50
FIGURE 24 TOTAL INVESTMENT RAISED BY THE START-UPS 52
FIGURE 25 BIOSENSORS MARKET, BY TECHNOLOGY 54
FIGURE 26 SEGMENTATION OF ELECTROCHEMICAL BIOSENSORS 56
FIGURE 27 SEGMENTATION OF OPTICAL BIOSENSORS 60
FIGURE 28 SEGMENTATION OF PIEZOELECTRIC BIOSENSORS 62
FIGURE 29 BIOSENSORS MARKET, BY PRODUCT 65
FIGURE 30 BIOSENSORS MARKET, BY APPLICATION (2017–2022) 73
FIGURE 31 BIOSENSORS MARKET FOR POC APPLICATIONS IN APAC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 75
FIGURE 32 NORTH AMERICA TO HOLD THE LARGEST SIZE OF THE BIOSENSORS MARKET FOR GLUCOSE MONITORING APPLICATIONS BY 2022 79
FIGURE 33 EUROPE TO HOLD THE LARGEST SHARE OF THE BIOSENSORS MARKET FOR COAGULATION MONITORING APPLICATIONS BY 2022 81
FIGURE 34 EUROPE TO HOLD THE LARGEST SIZE OF THE BIOSENSORS MARKET FOR TUMOR OR CANCER MARKERS IN 2017 83
FIGURE 35 NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS BY 2022 87
FIGURE 36 NON-WEARABLE BIOSENSORS TO HOLD A LARGER SHARE OF THE BIOSENSORS MARKET FOR HOME DIAGNOSTICS APPLICATIONS BY 2022 89
FIGURE 37 BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS IN APAC TO GROW AT THE HIGHEST RATE BETWEEN 2017 AND 2022 91
FIGURE 38 NON-WEARABLE BIOSENSORS TO DOMINATE THE BIOSENSORS MARKET FOR RESEARCH LAB APPLICATIONS DURING THE FORECAST PERIOD 93
FIGURE 39 BIOSENSORS MARKET FOR BIODEFENSE APPLICATIONS IN APAC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 94
FIGURE 40 MARKET FOR WEARABLE BIOSENSORS FOR BIODEFENSE APPLICATIONS TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 97
FIGURE 41 BIOSENSORS MARKET FOR ENVIRONMENTAL MONITORING APPLICATIONS IN APAC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 98
FIGURE 42 MARKET FOR WEARABLE SENSORS FOR ENVIRONMENTAL MONITORING APPLICATIONS TO GROW AT A HIGHER RATE DURING THE FORECAST PERIOD 101
FIGURE 43 GEOGRAPHIC SNAPSHOT OF THE BIOSENSORS MARKET (2016) 106
FIGURE 44 SNAPSHOT OF THE BIOSENSORS MARKET IN NORTH AMERICA 108
FIGURE 45 SNAPSHOT OF THE BIOSENSORS MARKET IN EUROPE 111
FIGURE 46 SNAPSHOT OF THE BIOSENSORS MARKET IN APAC 114
FIGURE 47 MARKET SHARE ANALYSIS OF KEY PLAYERS IN THE BIOSENSORS INDUSTRY, 2016 118
FIGURE 48 BIOSENSORS MARKET OVERVIEW: DIVE ANALYSIS 121
FIGURE 49 MARKET EVOLUTION FRAMEWORK—NEW PRODUCT LAUNCHES/DEVELOPMENTS EMERGED AS THE MAJOR STRATEGY ADOPTED BY THE MARKET PLAYERS 124
FIGURE 50 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES AND DEVELOPMENTS WERE THE KEY GROWTH STRATEGIES 124
FIGURE 51 ABBOTT LABORATORIES: COMPANY SNAPSHOT 129
FIGURE 52 ABBOTT LABORATORIES: PRODUCTS OFFERINGS 130
FIGURE 53 ABBOTT LABORATORIES: BUSINESS STRATEGIES 131
FIGURE 54 F. HOFFMAN-LA ROCHE LTD.: BUSINESS OVERVIEW 132
FIGURE 55 F. HOFFMAN-LA ROCHE LTD.: PRODUCTS OFFERINGS 133
FIGURE 56 F. HOFFMAN-LA ROCHE LTD.: BUSINESS STRATEGIES 134
FIGURE 57 MEDTRONIC, INC.: BUSINESS OVERVIEW 135
FIGURE 58 MEDTRONIC, INC.: PRODUCTS OFFERINGS 136
FIGURE 59 MEDTRONIC, INC.: BUSINESS STRATEGIES 137
FIGURE 60 UNIVERSAL BIOSENSORS, INC.: BUSINESS OVERVIEW 139
FIGURE 61 UNIVERSAL BIOSENSORS, INC.: PRODUCTS OFFERINGS 140
FIGURE 62 UNIVERSAL BIOSENSORS, INC.: BUSINESS STRATEGIES 141
FIGURE 63 SIEMENS AG: BUSINESS OVERVIEW 143
FIGURE 64 SIEMENS AG: PRODUCTS OFFERINGS 144
FIGURE 65 SIEMENS AG: BUSINESS STRATEGIES 144
FIGURE 66 LIFESCAN, INC.: PRODUCTS OFFERINGS 146
FIGURE 67 LIFESCAN, INC.: BUSINESS STRATEGIES 147
FIGURE 68 LIFESENSORS, INC.: PRODUCTS OFFERINGS 148
FIGURE 69 LIFESENSORS, INC.: BUSINESS STRATEGIES 149
FIGURE 70 NOVA BIOMEDICAL: PRODUCTS OFFERINGS 150
FIGURE 71 NOVA BIOMEDICAL: BUSINESS STRATEGIES 151
FIGURE 72 ACON LABORATORIES, INC.: PRODUCTS OFFERINGS 152
FIGURE 73 ACON LABORATORIES, INC.: BUSINESS STRATEGIES 153
FIGURE 74 PHARMACO-KINESIS CORPORATION: PRODUCTS OFFERINGS 154
FIGURE 75 PHARMACO-KINESIS CORPORATION: BUSINESS STRATEGIES 155
FIGURE 76 BAYER HEALTHCARE AG: BUSINESS OVERVIEW 156
FIGURE 77 BAYER HEALTHCARE AG: PRODUCTS OFFERINGS 157
FIGURE 78 BAYER HEALTHCARE AG: BUSINESS STRATEGIES 158
FIGURE 79 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 159
FIGURE 80 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERINGS 160
FIGURE 81 BIO-RAD LABORATORIES, INC.: BUSINESS STRATEGIES 161
FIGURE 82 DUPONT: COMPANY SNAPSHOT 165
FIGURE 83 DUPONT: PRODUCTS OFFERINGS 166
FIGURE 84 DUPONT: BUSINESS STRATEGIES 167
FIGURE 85 SYSMEX CORPORATION: COMPANY SNAPSHOT 168
FIGURE 86 SYSMEX CORPORATION: PRODUCTS OFFERINGS 169
FIGURE 87 SYSMEX CORPORATION: BUSINESS STRATEGIES 170

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.